Inventor · disambiguated record
Hong Wan
Also filed as: WAN HONG · WAN HONG I · WAN HONG IRIS
15 granted patents·13 pending applications·76 citations·filing 2004–2025
91Inventor score
Top patents by PatentIndex Score
28 records- 0197US11208459B2Constructs having a SIRP-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2020·Granted Dec 28, 2021·8 cites·54 claims
- 0296US10696730B2Constructs having a SIRP-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2018·Granted Jun 30, 2020·11 cites·54 claims
- 0396US10259859B2Constructs having a SIRP-α domain or variant thereofALX ONCOLOGY INC·Filed 2016·Granted Apr 16, 2019·35 cites·137 claims
- 0494US11242404B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2021·Granted Feb 8, 2022·3 cites·30 claims
- 0593US11639376B2Constructs having a SIRP-α domain or variant thereofALX ONCOLOGY INC·Filed 2020·Granted May 2, 2023·3 cites·28 claims
- 0692US12098214B2Combination therapies for treating cancerALX ONCOLOGY INC·Filed 2022·Granted Sep 24, 2024·2 cites·6 claims
- 0792US11613564B2Methods of treating cancerALX ONCOLOGY INC·Filed 2020·Granted Mar 28, 2023·3 cites·7 claims
- 0891US11939393B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2022·Granted Mar 26, 2024·1 cites·24 claims
- 0991US11401338B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2017·Granted Aug 2, 2022·6 cites·37 claims
- 1089US11795463B2Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·1 cites·16 claims
- 1185US11920136B2Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2021·Granted Mar 5, 2024·1 cites·47 claims
- 1285US2024343778A1Constructs having a sirp-alpha domain or variant thereofALX ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1384US11292850B2Antibodies against signal-regulatory protein α and methods of useALX ONCOLOGY INC·Filed 2019·Granted Apr 5, 2022·2 cites·62 claims
- 1482US2024228574A9Methods of treating cancerALX ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 1579US2024191242A1Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1678US2024287528A1Transglutaminase-mediated conjugationTALLAC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1777US2025368712A1Methods of treating cancerALX ONCOLOGY INC·Filed 2025·Application pending·0 cites
- 1876US2022242928A1Methods of treating cancerALX ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 1975US12404340B2Antibodies against signal-regulatory protein alpha and methods of useALX ONCOLOGY INC·Filed 2021·Granted Sep 2, 2025·0 cites·37 claims
- 2075US2024075101A1Combination therapies for treating cancerALX ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 2175US2022213166A1Methods of treating cancerALX ONCOLOGY INC·Filed 2022·Application pending·0 cites
- 2264US2024382610A1Nectin-4 antibodies and conjugatesTALLAC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2364US2021154269A1Combination therapies for treating cancerALX ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 2461US2024374746A1Sirp-alpha antibodies and conjugatesTALLAC THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2554US12343377B2Combination therapies comprising a hypomethylation agent for treating cancerALX ONCOLOGY INC·Filed 2021·Granted Jul 1, 2025·0 cites·17 claims
- 2649US2020400662A1Methods and reagents for reducing the interference of drugs that bind cd47 in serological assaysALX ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 2748US2022096649A1Immunomodulating polynucleotide conjugates and methods of useTALLAC THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2842US8088623B2Dominant selection marker for the transformation of fungiLECLERQUE ANDREAS·Filed 2004·Granted Jan 3, 2012·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Hong Wan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →